Peter M. Neupert

Companies

• Fortrea Holdings Inc.Board member Jul 3, 2023 to now¹
• Adaptive BiotechnologiesBoard member Jun 26, 2019 to now²
• LabCorpBoard member Jan 16, 2013 to now³
• Fortrea Holdings Inc.Chief executive officer May 16, 2025 to Aug 4, 2025⁴
• NextGen Healthcare Information SystemsBoard member Aug 19, 2013 to Aug 19, 2013⁵
• aQuantiveBoard member May 12, 2006 to May 12, 2006⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• FFortrea Holdings Inc. FTRE246,668 shares⁷$5.6M at $22.75May 14, 2026
• LabCorp LH13,784 shares⁸$4.4M at $318.21Feb 11, 2026
• ABAdaptive Biotechnologies ADPT130,625 shares⁹$3.1M at $24.02Aug 17, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 17, 2026Sold 69,690 shares at $25.16 of Adaptive Biotechnologies⁹
• Aug 17, 2026Sold 40,000 shares at $25.10 of Adaptive Biotechnologies⁹
• Aug 17, 2026Sold 15,000 shares at $25.23 of Adaptive Biotechnologies⁹
• Aug 17, 2026Exercised options 15,000 shares at $6.32 of Adaptive Biotechnologies⁹
• May 14, 2026Exercised options 148,536 shares of Fortrea Holdings Inc.⁷
• Mar 4, 2026Granted 15,625 shares of Adaptive Biotechnologies¹⁰
• Feb 11, 2026Exercised options 897 shares of LabCorp⁸
• Aug 11, 2025Bought 32,500 shares at $6.26 of Fortrea Holdings Inc.¹¹
• Aug 8, 2025Bought 30,000 shares at $6.79 of Fortrea Holdings Inc.¹¹
• May 14, 2025Exercised options 7,282 shares of Fortrea Holdings Inc.¹²
• Mar 10, 2025Sold 10,000 shares at $7.05 of Adaptive Biotechnologies¹³
• Mar 10, 2025Exercised options 50,000 shares at $4.07 of Adaptive Biotechnologies¹³
• Mar 4, 2025Granted 15,394 shares of Adaptive Biotechnologies¹⁴
• Feb 6, 2025Exercised options 944 shares of LabCorp¹⁵
• Jul 18, 2024Exercised options 6,354 shares of Fortrea Holdings Inc.¹⁶
• Mar 12, 2024Exercised options 15,000 shares at $0.84 of Adaptive Biotechnologies¹⁷
• Mar 4, 2024Granted 31,328 shares of Adaptive Biotechnologies¹⁸
• Feb 7, 2024Exercised options 947 shares of LabCorp¹⁹
• Dec 13, 2023Exercised options 100,000 shares at $0.84 of Adaptive Biotechnologies²⁰
• Aug 23, 2023Bought 11,000 shares at $25.30 of Fortrea Holdings Inc.²¹
• Mar 6, 2023Granted 14,775 shares of Adaptive Biotechnologies²²
• Feb 11, 2023Exercised options 742 shares of LabCorp²³
• Feb 16, 2022Bought 600 shares at $264.57 of LabCorp²⁴
• Feb 16, 2022Bought 1,600 shares at $263.98 of LabCorp²⁴
• Feb 16, 2022Bought 1,300 shares at $262.85 of LabCorp²⁴